← Back to Search

MS Participant with Cognitive Dysfunction for Cognitive Impairment (HOBSCOTCH-MS Trial)

N/A

Recruiting

Led By Heather A Wishart, PhD

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Literate, English-speaking with grade 12 or equivalent in education

Self-reported diagnosis of MS

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (pre-hobscotch-ms) and post-hobscotch-ms, approximately 9 weeks later.

Awards & highlights

HOBSCOTCH-MS Trial Summary

This trial is testing whether a program called HOBSCOTCH, which helps people with epilepsy manage their condition at home, can be adapted and used by people with multiple sclerosis (MS). The trial

Who is the study for?

This trial is for people aged 20-65 with MS who feel they have memory or cognitive issues. They must be able to read and speak English, have completed at least a grade 12 level of education, and have access to a telephone and the internet.Check my eligibility

What is being tested?

The HOBSCOTCH program for epilepsy self-management is being tested to see if it can help improve the quality of life for those with MS. Participants will attend nine virtual sessions with a coach and complete questionnaires about their condition before and after these sessions.See study design

What are the potential side effects?

Since this intervention involves educational training rather than medication, traditional side effects are not expected. However, participants may experience fatigue or stress from attending regular sessions or completing surveys.

HOBSCOTCH-MS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have completed at least 12 years of education and can speak and read English.

Select...

I have been diagnosed with multiple sclerosis.

Select...

I am between 20 and 65 years old.

HOBSCOTCH-MS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (pre-hobscotch-ms) and post-hobscotch-ms, approximately 9 weeks later.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (pre-hobscotch-ms) and post-hobscotch-ms, approximately 9 weeks later.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-hobscotch-ms) and post-hobscotch-ms, approximately 9 weeks later. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in quality of life as measured by comparing FAMS-Functional Assessment of Multiple Sclerosis v4.0 scores pre- and post-HOBSCOTCH-MS intervention.

Change in subjective cognition as measured by comparing Neuro-QOL Item Bank v2.0 Cognitive Function scores pre- and post-HOBSCOTCH-MS intervention.

Secondary outcome measures

Change in objective cognition as measured by comparing California Verbal Learning Test-III scores pre- and post-HOBSCOTCH-MS intervention.

Change in objective cognition as measured by comparing Symbol-Digit Modalities Test scores pre- and post-HOBSCOTCH-MS intervention.

HOBSCOTCH-MS Trial Design

1Treatment groups

Experimental Treatment

Group I: MS Participant with Cognitive DysfunctionExperimental Treatment1 Intervention

Participants will receive the HOBSCOTCH-MS intervention consisting of 1:1 sessions delivered once per week including: 1 pre-HOBSCOTCH Session (on webcam or by phone) 1 educational session (on webcam) 6 HOBSCOTCH intervention sessions (webcam or phone) 1 wrap-up session (webcam or phone)

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor

524 Previous Clinical Trials

2,543,329 Total Patients Enrolled

Heather A Wishart, PhDPrincipal InvestigatorDartmouth-Hitchcock Medical Center

Elaine T Kiriakopoulos, MD, MPH, MScPrincipal InvestigatorDartmouth-Hitchcock Medical Center

1 Previous Clinical Trials

5 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this clinical trial?

"In order to be eligible for this trial, potential participants must exhibit cognitive impairment and fall within the age range of 20 to 65. The study is seeking approximately 10 individuals to participate."

Answered by AI

Is the enrollment for this trial currently open?

"Indeed, clinicaltrials.gov indicates that this trial is currently seeking eligible participants. The study was initially listed on January 1st, 2024 and underwent its most recent update on January 29th, 2024."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)

Elaine T. Kiriakopoulos 2024. "HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06145737.

All > Mci